BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37877974)

  • 1. Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patients.
    Osorio RC; Haddad AF; Hart DM; Goldrich N; Badani A; Kabir AS; Juncker R; Oh JY; Carrete L; Peeran Z; Chalif EJ; Zheng AC; Braunstein S; Theodosopoulos PV; El-Sayed IH; Gurrola J; Kunwar S; Blevins LS; Aghi MK
    J Neurosurg; 2024 Mar; 140(3):712-723. PubMed ID: 37877974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between socioeconomic status and presenting characteristics and extent of disease in patients with surgically resected nonfunctioning pituitary adenoma.
    Cote DJ; Ruzevick JJ; Kang KM; Pangal DJ; Bove I; Carmichael JD; Shiroishi MS; Strickland BA; Zada G
    J Neurosurg; 2022 Dec; 137(6):1699-1706. PubMed ID: 35395639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma knife radiosurgery for medically and surgically refractory prolactinomas.
    Pouratian N; Sheehan J; Jagannathan J; Laws ER; Steiner L; Vance ML
    Neurosurgery; 2006 Aug; 59(2):255-66; discussion 255-66. PubMed ID: 16883166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic predictors of case presentations and outcomes in 225 nonfunctional pituitary adenoma resections.
    Osorio RC; Pereira MP; Joshi RS; Donohue KC; Sneed P; Braunstein S; Theodosopoulos PV; El-Sayed IH; Gurrola J; Kunwar S; Blevins LS; Aghi MK
    J Neurosurg; 2022 May; 136(5):1325-1336. PubMed ID: 34598141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis.
    Yagnik KJ; Erickson D; Bancos I; Atkinson JLD; Choby G; Peris-Celda M; Van Gompel JJ
    Pituitary; 2021 Dec; 24(6):978-988. PubMed ID: 34580821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare disparities in pituitary surgery: a systematic review.
    Sabahi M; Maroufi SF; Wierzbicka A; Maniakhina L; Adada B; Borghei-Razavi H
    Neurosurg Focus; 2023 Nov; 55(5):E15. PubMed ID: 37913542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between tumor volume and serum prolactin and its effect on surgical outcomes in a cohort of 219 prolactinoma patients.
    Osorio RC; Pereira MP; Oh T; Joshi RS; Haddad AF; Pereira KM; Donohue KC; Peeran Z; Carson W; Badani A; Wang EJ; Sudhir S; Chandra A; Jain S; Beniwal A; Gurrola J; El-Sayed IH; Blevins LS; Theodosopoulos PV; Kunwar S; Aghi MK
    J Neurosurg; 2023 Jun; 138(6):1669-1679. PubMed ID: 36242577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
    Andereggen L; Frey J; Andres RH; El-Koussy M; Beck J; Seiler RW; Christ E
    Endocrine; 2017 Jan; 55(1):223-230. PubMed ID: 27688009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery as first-line treatment for prolactinoma? Discussion of the literature and results of a consecutive series of surgically treated patients.
    Ottenhausen M; Conrad J; Wolters LM; Ringel F
    Neurosurg Rev; 2023 May; 46(1):128. PubMed ID: 37249700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactinomas in children under 14. Clinical presentation and long-term follow-up.
    Liu Y; Yao Y; Xing B; Lian W; Deng K; Feng M; Wang R
    Childs Nerv Syst; 2015 Jun; 31(6):909-16. PubMed ID: 25771923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management considerations in cystic prolactinomas-a single center case series.
    Nevzati E; Chatain GP; Carr SB; Lillehei KO; Kerr JM
    Endocrine; 2020 Jan; 67(1):58-66. PubMed ID: 31773633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery.
    Han YL; Chen DM; Zhang C; Pan M; Yang XP; Wu YG
    Medicine (Baltimore); 2018 Nov; 97(45):e13198. PubMed ID: 30407358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative preoperative characteristics and postoperative outcomes at a private versus a safety-net hospital following endoscopic endonasal transsphenoidal resection of pituitary adenomas.
    Cyprich J; Pangal DJ; Rutkowski M; Donoho DA; Shiroishi M; Jason Liu CS; Carmichael JD; Zada G
    J Neurosurg; 2020 Feb; 134(3):742-749. PubMed ID: 32109866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients.
    Kreutzer J; Buslei R; Wallaschofski H; Hofmann B; Nimsky C; Fahlbusch R; Buchfelder M
    Eur J Endocrinol; 2008 Jan; 158(1):11-8. PubMed ID: 18166812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of medical and surgical treatments in giant prolactinoma: a single-center experience.
    Cander S; Oz Gul O; Eylemer E; Gullulu Boz E; Gunes E; Hakyemez B; Yilmazlar S; Ersoy C
    Hormones (Athens); 2021 Sep; 20(3):491-498. PubMed ID: 34236607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transnasal surgery for prolactin-secreting pituitary adenomas in childhood and adolescence.
    Abe T; Lüdecke DK
    Surg Neurol; 2002 Jun; 57(6):369-78; discussion 378-9. PubMed ID: 12176193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Technique and Efficacy Analysis of Extra-pseudocapsular Transnasal Transsphenoidal Surgery for Pituitary Microprolactinoma.
    Wan XY; Li LH; Chen J; Wang JW; Liu YC; Huang YM; Shu K; Buchfelder M; Fahlbusch R; Lei T
    Curr Med Sci; 2022 Dec; 42(6):1140-1147. PubMed ID: 36547872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PRolaCT studies - a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma.
    Zandbergen IM; Zamanipoor Najafabadi AH; Pelsma ICM; van den Akker-van Marle ME; Bisschop PHLT; Boogaarts HDJ; van Bon AC; Burhani B; le Cessie S; Dekkers OM; Drent ML; Feelders RA; de Graaf JP; Hoogmoed J; Kapiteijn KK; van der Klauw MM; Nieuwlaat WCM; Pereira AM; Stades AME; van de Ven AC; Wakelkamp IMMJ; van Furth WR; Biermasz NR;
    Trials; 2021 Sep; 22(1):653. PubMed ID: 34563236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative remission of non-invasive lactotroph pituitary tumor: A single-center experience.
    Lasolle H; Teulade M; Lapras V; Vasiljevic A; Borson-Chazot F; Jouanneau E; Raverot G
    Ann Endocrinol (Paris); 2022 Feb; 83(1):1-8. PubMed ID: 34871604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operative treatment of cystic prolactinomas: a retrospective study.
    Su W; He K; Yang Y; Xu J; Li X; Tang H; Yang J; Yang L
    BMC Endocr Disord; 2023 May; 23(1):99. PubMed ID: 37143054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.